다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
PloS one, v.7 no.3, 2012년, pp.e32764 -
Ren, Xiaohui (Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China) , Cui, Xiangli (Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China) , Lin, Song (Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China) , Wang, Junmei (Beijing Neurosurgical Institute, Beijing, China) , Jiang, Zhongli (Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China) , Sui, Dali (Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China) , Li, Jing (Neurosurgery, Capital Medical University, Beijing Tiantan Hospital, Beijing, China) , Wang, Zhongcheng (Beijing Neurosurgical Institute, Beijing, China)
AI-Helper
ObjectiveTo characterize co-deletion of chromosome 1p/19q and IDH1/2 mutation in Chinese brain tumor patients and to assess their associations with clinical features.MethodsIn a series of 528 patients with gliomas, pathological and radiological materials were reviewed. Pathological constituents of t...
1 Ohgaki H Kleihues P 2005 Epidemiology and etiology of gliomas. Acta Neuropathol 109 93 108 15685439
2 Louis DN Ohgaki H Wiestler OD Cavenee WK Burger PC 2007 The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 97 109 17618441
3 Schwartzbaum JA Fisher JL Aldape KD Wrensch M 2006 Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2 494 503, 1–516 16932614
4 Kraus JA Koopmann J Kaskel P Maintz D Brandner S 1995 Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54 91 95 7815084
5 van den Bent MJ Carpentier AF Brandes AA Sanson M Taphoorn MJ 2006 Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24 2715 2722 16782911
6 Cairncross G Berkey B Shaw E Jenkins R Scheithauer B 2006 Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24 2707 2714 16782910
7 Kros JM Gorlia T Kouwenhoven MC Zheng PP Collins VP 2007 Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome. J Neuropathol Exp Neurol 66 545 551 17549014
8 Cairncross JG Ueki K Zlatescu MC Lisle DK Finkelstein DM 1998 Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90 1473 1479 9776413
9 Kaloshi G Benouaich-Amiel A Diakite F Taillibert S Lejeune J 2007 Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68 1831 1836 17515545
10 Kujas M Lejeune J Benouaich-Amiel A Criniere E Laigle-Donadey F 2005 Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol 58 322 326 16049942
11 Hoang-Xuan K Capelle L Kujas M Taillibert S Duffau H 2004 Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22 3133 3138 15284265
12 Jenkins RB Blair H Ballman KV Giannini C Arusell RM 2006 A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66 9852 9861 17047046
13 Parsons DW Jones S Zhang X Lin JC Leary RJ 2008 An integrated genomic analysis of human glioblastoma multiforme. Science 321 1807 1812 18772396
14 Watanabe T Nobusawa S Kleihues P Ohgaki H 2009 IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174 1149 1153 19246647
15 Sanson M Marie Y Paris S Idbaih A Laffaire J 2009 Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27 4150 4154 19636000
16 Yan H Parsons DW Jin G McLendon R Rasheed BA 2009 IDH1 and IDH2 mutations in gliomas. N Engl J Med 360 765 773 19228619
17 Bleeker FE Atai NA Lamba S Jonker A Rijkeboer D 2010 The prognostic IDH1(R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropathol 119 487 494 20127344
18 Larjavaara S Mantyla R Salminen T Haapasalo H Raitanen J 2007 Incidence of gliomas by anatomic location. Neuro Oncol 9 319 325 17522333
19 Duffau H Capelle L 2004 Preferential brain locations of low-grade gliomas. Cancer 100 2622 2626 15197805
20 Zlatescu MC TehraniYazdi A Sasaki H Megyesi JF Betensky RA 2001 Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61 6713 6715 11559541
21 Mueller W Hartmann C Hoffmann A Lanksch W Kiwit J 2002 Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 161 313 319 12107116
22 Huang L Jiang T Yuan F Li GL Liu EZ 2008 Correlations between molecular profile and tumor location in Chinese patients with oligodendroglial tumors. Clin Neurol Neurosurg 110 1020 1024 18845382
23 Goze C Rigau V Gibert L Maudelonde T Duffau H 2009 Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis? J Neurooncol 91 1 5 18726074
24 Wu A Aldape K Lang FF 2010 High rate of deletion of chromosomes 1p and 19q in insular oligodendroglial tumors. J Neurooncol 99 57 64 20035368
25 Lai A Kharbanda S Pope WB Tran A Solis OE 2011 Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol 29 4482 4490 22025148
26 Ambros PF Ambros IM 2001 Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 37 492 504 11745887
27 Yasargil MG Reeves JD 1992 Tumours of the limbic and paralimbic system. Acta Neurochir (Wien) 116 147 149 1502948
28 Sanai N Polley MY Berger MS 2010 Insular glioma resection: assessment of patient morbidity, survival, and tumor progression. J Neurosurg 112 1 9 19612970
29 Lang FF Olansen NE DeMonte F Gokaslan ZL Holland EC 2001 Surgical resection of intrinsic insular tumors: complication avoidance. J Neurosurg 95 638 650 11596959
30 Laigle-Donadey F Martin-Duverneuil N Lejeune J Criniere E Capelle L 2004 Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology 63 2360 2362 15623700
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.